To the best of our knowledge, 11 protective and 10 resilience variants have been reported in AD, with previous reports primarily focusing on the role of genetic variation in modulating AD risk among homozygous or heterozygous APOE ε4 carriers8–14. This evidence concerns the gene APOE and Alzheimer disease.